欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2022, Vol. 27 ›› Issue (1): 15-24.doi: 10.12092/j.issn.1009-2501.2022.01.003

• 基础研究 • 上一篇    下一篇

琥珀酸曲格列汀对2型糖尿病小鼠肠道菌群的改变

陈 倩1,王亚峰2,朵德龙2,常亚娥2,严英俊2,段坤坤1
  

  1. 1青海大学医学院,西宁 810000,青海;2青海省人民医院药学部,西宁 810007,青海
  • 收稿日期:2021-06-16 修回日期:2022-01-14 出版日期:2022-01-26 发布日期:2022-02-09
  • 通讯作者: 王亚峰,男,在读博士,硕士生导师,主任药师,研究方向:医院药学。 Tel: 13709732265 E-mail: wyf8289@163.com
  • 作者简介:陈倩,女,硕士研究生在读,研究方向:医院药学。 Tel: 15597028147 E-mail: 846264596@qq.com
  • 基金资助:
    青海省科技厅科技成果转化专项项目(2020-SF-131)

Trigliptin succinate have an effect on gut microbiota of type 2 diabetic mice

CHEN Qian1, WANG Yafeng 2, DUO Delong2, CHANG Ya'e2, YAN Yingjun2, DUAN Kunkun1   

  1. 1 Qinghai University Medical College, Xining 810000, Qinghai, China
  • Received:2021-06-16 Revised:2022-01-14 Online:2022-01-26 Published:2022-02-09

摘要: 目的:研究琥珀酸曲格列汀对2型糖尿病小鼠肠道菌群的影响。方法:16S rRNA高通量测序法对健康组、T2DM组、琥珀酸曲格列汀组、磷酸西格列汀组小鼠肠道菌群进行测序,利用QIME对数据进行过滤,对物种进行分类和注释。对样品的Alpha多样性指数和Beta多样性指数进行了分析,比较4组的样本菌群丰富度和多样性。结果:结果表明健康组、T2DM组、琥珀酸曲格列汀组、磷酸西格列汀组小鼠肠道菌群结构差异具有统计学意义。与健康组相比,T2DM组的厚壁菌门与拟杆菌门的比值降低,与琥珀酸曲格列汀组比较,T2DM组的Cyanobacteria、Verrucomicrobia、Tenericutes差异具有统计学意义(P<0.05);T2DM组候选生物标志物可能是:Bacilli、Lactobacillales、Lactococcus、Streptococcaceae;琥珀酸曲格列汀组候选生物标志物可能是:Bacteroidia、Bacteroidetes、Bacteroidales、Prevotella、Paraprevotellaceae、Parabacteroides、Porphyromonadaceae;磷酸西格列汀组候选生物标志物可能是:Lactobacillus、Lactobacillaceae、Helicobacter。 结论:使用琥珀酸曲格列汀改善小鼠肠道菌落,可能通过改善肠道菌群而达到降糖效果。

关键词: 2型糖尿病, 肠道菌群, 琥珀酸曲格列汀, 16S rRNA

Abstract: AIM: To study the effects of trigliptin succinate on gut microbiota of type 2 diabetic mice.  METHODS: 16S rRNA high-throughput sequencing method was used to sequence the intestinal flora of mice in the healthy group, the T2DM group, the trigliptin succinate group and the sitagliptin phosphate group. QIME was used to filter the data, classify and annotate the species. Alpha diversity index and Beta diversity index of the samples were analyzed.The richness and diversity of bacteria in the four groups were compared. RESULTS: The gut microbiota structure of mice in the healthy group, the T2DM group, the trigliptin succinate group and the setagliptin phosphate group were significantly different. The results showed that the ratio of Firmicutes to Bacteroidetes was decreased compared with that in the healthy group. Cyanobacteria, Verrucomicrobia and Tenericutes had significant differences (P<0.05). Potential biomarkers for T2DM group were Bacilli, Lactobacillales, Lactococcus and Streptococcaceae. Candidate biomarkers of trigliptin succinate group may be Bacteroidia, Bacteroidetes, Bacteroidales, Prevotella, Paraprevotellaceae, Parabacteroides, Porphyromonadaceae; The candidate biomarkers of sitagliptin phosphate group may be Lactobacillus, Lactobacillaceae and Helicobacter. CONCLUSION: The intestinal flora of mice in the trigliptin succinate group was significantly different from that in the healthy group and the T2DM group. Using trigliptin succinate to improve the intestinal flora of mice might achieve the hypoglycemic effect by improving the intestinal flora.

Key words: type 2 diabetes, gut microbiota, trigliptin succinate, 16S rRNA

中图分类号: